News from karo pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

21 Jul, 2020, 07:34 BST Karo Pharma: Second-quarter report 2020

Q2, April - June Net sales amounted to MSEK 688.9 (387.4). This corresponds to an increase of 78% for the period. The organic growth during the...


26 May, 2020, 04:14 BST Annual General Meeting 2020 in Karo Pharma Aktiebolag

At today's annual general meeting of Karo Pharma, the following decisions were passed. The annual general meeting resolved to adopt the income...


08 May, 2020, 12:28 BST Karo Pharma Acquires Pevaryl® Brand Portfolio From Cilag GmbH International, an Affiliate of Johnson & Johnson

Karo Pharma Aktiebolag ("Karo Pharma") today announces the signing and closing of the acquisition of the remaining European rights to the Pevaryl®...


29 Apr, 2020, 15:34 BST Karo Pharma: Interim report Q1 2020

January - March Net sales amounted to MSEK 793.6 (420.8). This corresponds to an increase of 89% for the period. The organic growth during the first...


01 Apr, 2020, 15:09 BST Karo Pharma Enters the Swiss Market with Direct Presence by Acquiring Hygis SA

Karo Pharma AB (Karo) has today acquired Hygis SA (Hygis), a Swiss distributing company with exclusive distribution rights to Karo's brands MultiGyn...


01 Apr, 2020, 14:26 BST Karo Pharma Publishes the 2019 Annual Report

Today, on 1 April 2020, Karo Pharma is publishing its annual report for 2019 on the company's website, www.karopharma.com. ABOUT KARO PHARMA Karo...


27 Mar, 2020, 12:32 GMT Karo Pharma Postpones the Annual General Meeting to 25 May, 2020

The board of directors of Karo Pharma Aktiebolag ("Karo Pharma") has resolved to postpone the Annual General Meeting to 25 May, 2020. The previously...


02 Mar, 2020, 11:15 GMT Karo Pharma Completes the Acquisition of Product Portfolio from LEO Pharma

Karo Pharma Aktiebolag ("Karo Pharma") today announces that the acquisition of the intimate care and dermatology product portfolio from LEO Pharma...


19 Feb, 2020, 07:18 GMT Karo Pharma: Year-end Report 2019

OCTOBER - DECEMBER Net sales amounted to MSEK 649.3 (463.3). This corresponds to an increase of 40% for the period. The organic growth during the...


04 Feb, 2020, 17:26 GMT Termination of Karo Agreement with Pfizer

Karo Pharma AB ("Karo") has been informed by Pfizer Inc. ("Pfizer") about its decision to terminate the Research Collaboration and License Agreement, ...


23 Dec, 2019, 11:39 GMT Karo Pharma Acquires Product Portfolio From LEO Pharma

Karo Pharma acquires a focused intimate care and dermatology product portfolio from the Danish pharmaceutical company LEO Pharma for 90 MEUR. The...


11 Dec, 2019, 12:14 GMT Åsa Riisberg Leaves the Board of Directors of Karo Pharma at her Own Request

Åsa Riisberg has notified the Board of Directors of Karo Pharma that she, due to a number of time-consuming commitments, wishes to leave her position ...


27 Nov, 2019, 07:26 GMT Karo Pharma Divests Hydrokortison Trimb to Evolan Pharma

As previously communicated, Karo Pharma Aktiebolag ("Karo Pharma") voluntarily and within a certain time undertook to divest Hydrokortison Trimb and...


20 Nov, 2019, 10:14 GMT Further Clarification Regarding the ROR-gamma Project

On November 5, 2019, Karo Pharma Aktiebolag ("Karo Pharma") issued a press release regarding the Pfizer collaboration and license agreement related...


15 Nov, 2019, 07:11 GMT Karo Pharma - Interim Report January - September 2019

JULY - SEPTEMBER Net sales amounted to MSEK 443.7 (395.3). This corresponds to an increase of 12% for the period, of which the acquired operations...


05 Nov, 2019, 07:49 GMT Termination of Project Regarding ROR-gamma

In December 2011, Karo Pharma Aktiebolag ("Karo Pharma") entered into a research collaboration and license agreement with Pfizer, with the purpose of ...


31 Oct, 2019, 16:12 GMT New Number of Shares and Votes in Karo Pharma

As previously announced, Karo Pharma Aktiebolag ("Karo Pharma") has completed a rights issue of 60,700,422 shares, with the purpose of repaying a...


08 Oct, 2019, 12:21 BST Karo Pharma Postpones Publication of the Interim Report for the Period January - September 2019

The board of directors of Karo Pharma Aktiebolag ("Karo Pharma") has resolved to postpone the publication of the interim report for the period...


20 Sep, 2019, 15:15 BST Extraordinary General Meeting in Karo Pharma Aktiebolag on 20 September 2019

At today's extraordinary general meeting in Karo Pharma, the following resolution was passed. The general meeting resolved, in accordance with the...


19 Sep, 2019, 16:51 BST Karo Pharma's Planned Rights Issue is Intended to Amount to Approximately SEK 2 Billion

As communicated on 12 September 2019, Karo Pharma Aktiebolag ("Karo Pharma") has completed its acquisition of Trimb Holding AB. The acquisition was...


12 Sep, 2019, 16:21 BST Karo Pharma Completes the Acquisition of Trimb and Carries out Management Changes

Karo Pharma Aktiebolag ("Karo Pharma") today announces that the acquisition of all the shares of Trimb Holding AB ("Trimb") from Avista Capital...


04 Sep, 2019, 13:21 BST The Swedish Competition Authority Approves Karo Pharma's Acquisition of Trimb and Karo Pharma Continues the Company's Efforts Elated to Internalisation of Sales and Marketing

Karo Pharma Aktiebolag (the "Company" or "Karo Pharma") today announces that the acquisition of all the shares of Trimb Holding AB ("Trimb") from...


28 Aug, 2019, 12:17 BST NOTICE OF EXTRAORDINARY GENERAL MEETING IN KARO PHARMA AKTIEBOLAG

The shareholders of Karo Pharma Aktiebolag, reg. no 556309-3359, are given notice of an Extraordinary General Meeting, to be held on Friday 20...


14 Aug, 2019, 07:40 BST Jon Johnsson Appointed New CFO of Karo Pharma

Karo Pharma Aktiebolag (publ) ("Karo Pharma") has appointed Jon Johnsson as the new CFO of Karo Pharma, replacing Mats-Olof Wallin, who will retire...


19 Jul, 2019, 15:32 BST Clarification of the Statement in the Interim Report Published 19 July 2019 Regarding the Rights Issue with Pre-emptive Rights

Karo Pharma Aktiebolag ("Karo Pharma") today published its interim report for the period January - June 2019. On page 2 of the Swedish language...